Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yi-Han Lin
Sodium Glucose Co-Transporter 2 Inhibitors and Cardiovascular Event Protections: How Applicable Are Clinical Trials and Observational Studies to Real-World Patients?
BMJ Open Diabetes Research and Care
Endocrinology
Metabolism
Diabetes
Related publications
Pdb1 - Acute Renal Outcomes With Sodium Glucose Co-Transporter 2 Inhibitors- Real World Data Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Sodium-Glucose Co-Transporter Type-2 Inhibitors: Pharmacology and Peri-Operative Considerations
Anaesthesia
Anesthesiology
Pain Medicine
Sodium–glucose Co-Transporter 2 Inhibitors: Think Twice About Diabetic Ketoacidosis
Sodium‐glucose Co‐transporter Type‐2 Inhibitors: Is the Message Getting Through?
Anaesthesia
Anesthesiology
Pain Medicine
Sodium-Glucose Co-Transporter-2 Inhibitors in Type 1 Diabetes—a Dangerous Ally
US Endocrinology
Endocrinology
Metabolism
Diabetes
Does Gender Influence the Cardiovascular Benefits Observed With Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors? A Meta-Regression Analysis
Cardiology and Therapy
Clinical Considerations When Introducing Sodium-Glucose Co-Transporter 2 Inhibition in Patients With Heart Failure
Circulation Reports
Clinical Relevance Between Sodium-Glucose Co-Transporter 2 Inhibitors and Lipid Profiles in Asian Patients With Type 2 Diabetes Mellitus: A Systematic Review With a Meta-Analysis of Randomized Controlled Trials
Journal of Pharmaceutical Health Care and Sciences
Sodium-Glucose Co-Transporter 2 Inhibitors in the Peri-Operative Period: A Warning to All Clinicians
BJU International
Urology
